GENEVA, July 27 -- SHANGHAI MINWEI BIOTECHNOLOGY CO., LTD filed a patent application (CN2025/077201) for “SIRNA INHIBITOR FOR INHIBITING EXPRESSION OF ANGIOTENSINOGEN AGT GENE AND USE THEREOF”. With publication no. WO/2026/152509, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 15/113
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....